ArticleAdvanced materials (Deerfield Beach, Fla.)2025
3D Printing for Neural Repair: Bridging the Gap in Regenerative Medicine.
Article in Advanced materials (Deerfield Beach, Fla.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Stem Cells in Post-Stroke Regenerative Therapy: Current Role of Wharton's Jelly Mesenchymal Stem Cells in the Orchestrum.Brain sciences · 2026Review
- Development of aBioactive materials · 2026Article
- Bioinspired Engineering of Streamlined Skeletal Interoception: Neural Bioprinted Piezoelectric Scaffolds for Neuro-Vascularized Bone Regeneration.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
- 3D Printing for Neural Repair: Bridging the Gap in Regenerative Medicine.Advanced materials (Deerfield Beach, Fla.) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Neurological disorders impose a substantial global health burden, compounded by the limited regenerative capacity of neural tissues and the absence of curative therapies. 3D bioprinting offers a transformative tool to model, replace, and regenerate neural tissues through the precise spatial organization of cells and biomaterials. In this perspective article, recent advances are examined in: i) the development of in vitro neural platforms for disease modeling and drug screening; ii) bioprinted acellular scaffolds designed to guide endogenous neural repair; and iii) cell-laden constructs that aim to replace or reconstruct damaged neural circuits. Key translational challenges are critically evaluated, including vascularization, immune integration, functional maturation, and replicating the complex cytoarchitectures of native neural tissues. Highlighting representative preclinical studies and emerging biofabrication technologies, we discuss how innovations in biomaterials, scaffold design, stem cell biology, and neuroengineering are converging to overcome existing limitations. Through tailored strategies and interdisciplinary collaboration, 3D bioprinting is poised to redefine therapeutic paradigms and drive the development of next-generation, personalized regenerative therapies for neurological diseases and injuries.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.